Clozapine for bipolar disorder: What do we know so far and what next?

Bipolar Disord. 2021 Mar;23(2):115-116. doi: 10.1111/bdi.13050.

Authors

Flavio Kapczinski^{1

2

3}, Bianca Pfaffenseller¹, Serdar M Dursun⁴, Taiane de Azevedo Cardoso¹

Affiliations

¹ Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
² Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, Brazil.
³ Graduate Program in Psychiatry, Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
⁴ Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.

PMID: 33719158
DOI: 10.1111/bdi.13050

No abstract available

Publication types

Editorial

MeSH terms

Antipsychotic Agents* / therapeutic use
Bipolar Disorder* / drug therapy
Clozapine* / adverse effects
Humans

Substances

Antipsychotic Agents
Clozapine